3 ASX Dividend Stocks Paying Investors While They Wait

With central banks keeping policy paths in sharp focus and 10Y bond yields edging higher, income investors are being asked to work harder for dependable cash flow. That is where Dividend Powerhouses with 5%+ yields and solid coverage come into play, offering income potential while capital is deployed. These stocks are designed to pay you while you wait. This article walks through three standouts from the screener and explains what makes each one worth a closer look.

The three stocks below are just a starting sample. The full screen surfaced 25 more companies with equally compelling dividend stories that are not covered here. To identify and analyze the highest conviction income ideas for your watchlist, go straight to the Dividend Powerhouses (3%+ Yield) screener.

CSL (ASX:CSL)

CSL is a global biopharmaceutical group that develops and manufactures plasma derived therapies, vaccines, and treatments for iron deficiency and kidney related conditions. Most of its revenue comes from CSL Behring, which generates about US$10.9b from plasma products, gene therapies, and recombinants, followed by CSL Vifor at roughly US$2.4b and CSL Seqirus at about US$2.2b. The company is a large player in its sector, with a market value of around A$64.5b.

CSL sits at the intersection of essential medicines and income investing. The stock has been hit by restructuring costs, a large one off loss and a fall in net margins to 9.1%, which helps explain why it has lagged the Australian Biotechs sector and why short term earnings look messy. Yet the core plasma and vaccine franchises remain central in rare disease and flu prevention, and the business continues to invest in new products like ANDEMBRY for hereditary angioedema. For investors looking at dividend powerhouses, the key question is whether this period of clean up and heavy spending is setting up a stronger earnings and cash flow story than the share price currently reflects.

CSL’s clean up phase and short term margin hit could be masking where the real story is heading. To see how analysts think earnings and cash flow might evolve from here, go through the analyst forecasts for CSL

Build your own income and healthcare shortlist

CSL and the two other dividend stocks in this article all came from a single screener, but the real advantage is in setting filters that match how you assess income, balance sheets and future earnings. Use our flexible Screener to shape your own watchlist, or start with one of our curated Investing Ideas.

Computershare (ASX:CPU)

Computershare is a global provider of share registry, corporate trust, employee share plan administration, mortgage and rental services, and communication and document processing tools. It generates most of its revenue from Issuer Services at about US$1.3b and Corporate Trust at roughly US$1b, with Employee Share Plans contributing around US$586m and Corporate & Other adding about US$475m. The company has a market value of roughly A$23.4b.

Income investors may want to keep Computershare on their radar because it combines fee based registry and trust operations with interest sensitive margin income, which can support earnings when rates are higher. Management has been sharpening the focus on core segments, investing in digitization and AI within Issuer Services and Employee Share Plans, and backing that up with a strong balance sheet and buybacks. At the same time, the story is not risk free, with dividend consistency, exposure to interest rate cuts and some client turnover in registry services all worth watching closely if you rely on this stock for income.

Computershare’s mix of fee income and rate sensitive margins could be masking where the real earnings story goes next. For the full picture, see the analysis report for Computershare

Commonwealth Bank of Australia (ASX:CBA)

Commonwealth Bank of Australia is a major retail and commercial bank offering everyday transaction accounts, savings, home loans, business lending, cards and a wide range of insurance and investment services across Australia, New Zealand and other markets. The bulk of its A$29.4b in business segment revenue comes from Retail Banking Services including Bankwest at about A$13.4b, followed by Business Banking at roughly A$9.7b and New Zealand at around A$3.0b, with Institutional Banking and Markets adding close to A$2.9b. The stock is one of the largest companies on the ASX, with a market value of about A$275.9b.

Income investors looking at Commonwealth Bank of Australia are weighing a rare mix of size, earnings quality and dividend potential against some clear pressure points. Net income of A$10.9b and a fully franked A$2.70 final dividend underline the bank’s ability to generate and return cash, supported by high capital and deposit funding levels that can help support payouts through cycles. On the other side of the ledger, a rich P/E multiple, an unstable dividend track record, low loan loss allowances and heavy spending on technology and AI mean you are paying up for a franchise that still has to prove it can keep earnings and margins moving in the right direction.

Commonwealth Bank of Australia’s rich P/E and fully franked payouts suggest the market already has high expectations, yet key drivers of earnings quality may be underappreciated. Step through the 1 key reward and 3 important warning signs

Seeking Alternatives Before The Crowd Moves

Fresh ideas move first. Breakout momentum, dropping entry points and under the radar stories rarely stay quiet for long. Before the best setups get caught, act early to explore opportunities that may still be developing.

• Identify early movers in beaten down sectors and scan a curated 10 high quality undervalued stocks that focuses on companies with relatively stronger balance sheets while prices are still adjusting.
• Follow developments in the next wave of automation and track hand picked companies in the 37 robotics and automation stocks as industrial and AI applications continue to evolve.
• Review potential opportunities related to energy transitions and explore a filtered 92 nuclear energy infrastructure stocks that highlights infrastructure businesses before they attract wider attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com